Clal Insurance Enterprises Holdings Ltd. (TLV:CLIS)
Israel
· Delayed Price · Currency is ILS · Price in ILA 10,100
+182 (1.84%)
Apr 24, 2025, 5:24 PM IDT
TLV:CLIS Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Premiums & Annuity Revenue | 8,911 | 9,495 | 9,844 | 9,012 | 8,028 | Upgrade
|
| Total Interest & Dividend Income | 4,095 | 3,660 | 2,757 | 2,088 | 1,140 | Upgrade
|
| Gain (Loss) on Sale of Investments | 10,585 | 5,571 | -6,948 | 11,766 | 3,983 | Upgrade
|
| Non-Insurance Activities Revenue | 1,554 | 1,083 | - | - | - | Upgrade
|
| Other Revenue | 456 | 390 | 383 | 339 | 311.91 | Upgrade
|
| Total Revenue | 26,902 | 21,458 | 7,234 | 24,980 | 14,709 | Upgrade
|
| Revenue Growth (YoY) | 25.37% | 196.63% | -71.04% | 69.83% | -25.74% | Upgrade
|
| Policy Benefits | 19,447 | 15,391 | 3,741 | 20,273 | 11,016 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 2,183 | 2,084 | 1,970 | 1,799 | 1,744 | Upgrade
|
| Selling, General & Administrative | 1,872 | 1,604 | 1,152 | 1,160 | 1,121 | Upgrade
|
| Provision for Bad Debts | 216 | 411 | - | - | - | Upgrade
|
| Non-Insurance Activities Expense | 1,219 | 905 | - | - | - | Upgrade
|
| Other Operating Expenses | 45 | 40 | 18 | 9 | 9.06 | Upgrade
|
| Total Operating Expenses | 24,995 | 20,452 | 6,896 | 23,265 | 13,890 | Upgrade
|
| Operating Income | 1,907 | 1,006 | 338 | 1,715 | 819.08 | Upgrade
|
| Interest Expense | -816 | -651 | -213 | -219 | -160.67 | Upgrade
|
| Earnings From Equity Investments | 14 | 8 | 3 | 29 | -4.19 | Upgrade
|
| Currency Exchange Gain (Loss) | -45 | 12 | 27 | -9 | -48.13 | Upgrade
|
| Other Non Operating Income (Expenses) | -9 | -2 | 1 | - | -0.39 | Upgrade
|
| EBT Excluding Unusual Items | 1,051 | 373 | 156 | 1,516 | 605.7 | Upgrade
|
| Asset Writedown | -10 | -26 | 39 | 82 | -19.76 | Upgrade
|
| Other Unusual Items | - | - | - | -17 | - | Upgrade
|
| Pretax Income | 1,041 | 347 | 195 | 1,581 | 585.94 | Upgrade
|
| Income Tax Expense | 317 | 124 | 68 | 494 | 143.27 | Upgrade
|
| Earnings From Continuing Ops. | 724 | 223 | 127 | 1,087 | 442.66 | Upgrade
|
| Minority Interest in Earnings | -6 | -3 | -6 | -5 | -3.99 | Upgrade
|
| Net Income | 718 | 220 | 121 | 1,082 | 438.68 | Upgrade
|
| Net Income to Common | 718 | 220 | 121 | 1,082 | 438.68 | Upgrade
|
| Net Income Growth | 226.36% | 81.82% | -88.82% | 146.65% | - | Upgrade
|
| Shares Outstanding (Basic) | 79 | 78 | 74 | 68 | 68 | Upgrade
|
| Shares Outstanding (Diluted) | 79 | 79 | 74 | 68 | 68 | Upgrade
|
| Shares Change (YoY) | 0.56% | 6.33% | 9.72% | 0.14% | 20.70% | Upgrade
|
| EPS (Basic) | 9.08 | 2.83 | 1.64 | 16.00 | 6.48 | Upgrade
|
| EPS (Diluted) | 9.03 | 2.79 | 1.62 | 15.97 | 6.48 | Upgrade
|
| EPS Growth | 223.66% | 72.22% | -89.86% | 146.45% | - | Upgrade
|
| Free Cash Flow | 1,536 | -4,344 | -2,609 | 7,061 | -1,276 | Upgrade
|
| Free Cash Flow Per Share | 19.33 | -54.96 | -35.10 | 104.23 | -18.86 | Upgrade
|
| Operating Margin | 7.09% | 4.69% | 4.67% | 6.87% | 5.57% | Upgrade
|
| Profit Margin | 2.67% | 1.03% | 1.67% | 4.33% | 2.98% | Upgrade
|
| Free Cash Flow Margin | 5.71% | -20.24% | -36.07% | 28.27% | -8.68% | Upgrade
|
| EBITDA | 1,972 | 1,065 | 660 | 2,040 | 1,139 | Upgrade
|
| EBITDA Margin | 7.33% | 4.96% | 9.12% | 8.17% | 7.74% | Upgrade
|
| D&A For EBITDA | 65 | 59 | 322 | 325 | 319.86 | Upgrade
|
| EBIT | 1,907 | 1,006 | 338 | 1,715 | 819.08 | Upgrade
|
| EBIT Margin | 7.09% | 4.69% | 4.67% | 6.87% | 5.57% | Upgrade
|
| Effective Tax Rate | 30.45% | 35.73% | 34.87% | 31.25% | 24.45% | Upgrade
|
| Revenue as Reported | 26,856 | 21,464 | 7,329 | 25,057 | 14,637 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.